Additional Relevant Details Eagle Pharmaceuticals shipped and launched the commercial availability of its Docetaxel Injection, Alcohol-free formula.  Previous Docetaxel Injections with the alcohol formula left patients showing symptoms of alcohol intoxication and required recovery periods after treatment.  This new alcohol-free formula is in response to the FDA's Drug Safety Communication warning (June '14) and is the first alcohol-free formula approved in the US.  Eagle estimates its annual sales of the generic docetaxel are $75 million.